The homeobox gene Hex induces T-cell-derived lymphomas when overexpressed in hematopoietic precursor cells

Oncogene

Volumn 22, Issue 42 REV. ISS. 4, 2003, Pages 6764-6773

  George, Alex ^a   Morse III, Herbert C ^b   Justice, Monica J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Hex; Retroviral transduction; T cell lymphoma

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HOMEODOMAIN PROTEIN; PROTEIN HEX; THY 1 ANTIGEN; UNCLASSIFIED DRUG; CD45 ANTIGEN; GREEN FLUORESCENT PROTEIN; HHEX PROTEIN, HUMAN; HHEX PROTEIN, MOUSE; PHOTOPROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL; BLOOD DISEASE; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENE INSERTION; GENE INSERTION SEQUENCE; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOBOX; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; RETROVIRUS; STEM CELL; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; FLOW CYTOMETRY; GENETICS; HUMAN; LYMPHOMA; METABOLISM; NEOPLASM; PHYSIOLOGY; TIME; VIROLOGY;

ANIMALIA; INSERTION SEQUENCES; UNIDENTIFIED INSERTION SEQUENCE; UNIDENTIFIED RETROVIRUS;

ANIMALS; ANTIGENS, CD45; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; LUMINESCENT PROTEINS; LYMPHOMA; MICE; MICE, INBRED C57BL; MODELS, GENETIC; NEOPLASMS; RETROVIRIDAE; STEM CELLS; TIME FACTORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0242521476     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206822     Document Type: Article

References (37)

1. Aster J, Xu L, Karnell F, Patriub V, Pui J and Pear W. (2000). Mol. Cell. Biol., 20, 7505-7515.
2. Bedford F, Ashworth A. Enver T and Wiedemann L. (1993). Nucleic Acids Res., 21, 1245-1249.
3. Behrens A. Sabapathy K, Graef I, Cleary M, Crabtree GR and Wagner EF. (2001). Proc. Natl. Acad. Sci. USA, 98, 1769-1774.
4. Bogue CW, Ganea GR, Sturm E, Ianucci R and Jacobs HC. (2000). Dev. Dyn., 19, 84-89.
5. Bogue CW, Zhang PX, McGrath J, Jacobs HC and Fuleihan RL. (2003). Proc. Natl. Acad. Sci. USA, 100, 556-561.
6. Crompton M, Bartlett T, MacGregor A, Manfioletti G, Buratti E, Giancotti V and Goodwin G. (1992). Nucleic Acids Res., 20, 5661-5667.
7. Goldfarb AN and Greenberg JM. (1994). Leuk. Lymphoma, 12, 157-166.
8. Hansen G and Justice MJ. (1999). Oncogene, 18, 6531-6539.
9. Hawley RG, Fong AZ, Reis MD, Zhang N, Lu M and Hawley TS. (1997). Cancer Res., 57, 337-345.
10. Hawley RG, Lieu FH, Fong AZ and Hawley TS. (1994). Gene Ther., 1, 136-138.
11. Ho CY, Houart C, Wilson SW and Stainier DY. (1999). Curr. Biol., 19, 1131-1134.
12. Hough MR, Reis MD, Singaraja R, Bryce DM, Kamel-Reid S, Dardick I, Breitman ML and Dube ID. (1998). Proc. Natl. Acad. Sci. USA, 95, 13853-13858.
13. Hromas R, Radich J and Collins S. (1993). Biochem. Biophys. Res. Commun., 195, 976-983.
14. Jayaraman PS, Frampton J and Goodwin G. (2000). Leuk. Res., 24, 1023-1031.
15. Jonkers J and Berns A. (1996). Biochim. Biophys. Acta, 1287, 29-57.
16. Keng VW, Yagi H, Ikawa M, Nagano T, Myint Z, Yamada K, Tanaka T, Sato A, Muramatsu I, Okabe M, Sato M and Noguchi T. (2000). Biochem. Biophys. Res. Commun., 276, 1155-1161.
17. Krosl J and Sauvageau G. (2000). Oncogene, 19, 5134-5141.
18. Liao W, Ho CY, Yan YL, Postlethwait J and Stainier DY. (2000). Development. 127, 4303-4313.
19. Look A. (1997). Science, 278, 1059-1064.
20. Mack DL, Liebowitz, DS, Cooper S, Ramsey H, Broxmeyer HE and Hromas R. (2002). Immunology, 107, 444-451.
21. Manfioletti G, Gattei V, Buratti E, Rustighi A, De IA, Aldinucci D. Goodwin G and Pinto A. (1995). Blood, 85, 1237-1245.
22. Martinez Barbera JP, Clements M. Thomas P, Rodriguez T, Meloy D, Kioussis D and Beddington RS. (2000). Development, 127, 2433-2445.
23. Morse HC 3rd, Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Jaffe ES, Kogan SC, MacLennan IC, Pattengale PK, Ward JM and Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium. (2002). Blood, 100, 246-258.
24. Mucenski ML. Taylor BA, Jenkins NA and Copeland NG. (1986). Mol. Cell. Biol., 6, 4236-4243.
25. Nakagawa T, Abe M, Yamazaki T, Miyashita H, Niwa H, Kokubun S and Sato Y. (2003). Arterioscler. Thromb. Vasc. Biol., 23, 231-237.
26. Newman CS, Chia F and Krieg PA. (1997). Mech. Dev., 66, 83-93.
27. Owens B and Hawley R. (2002). Stem Cells, 20, 364-379.
28. Persons DA, Allay JA, Allay ER, Ashmun RA, Orlic D, Jane SM, Cunningham JM and Nienhuis AW. (1999). Blood, 93, 488-499.
29. Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW and Orkin SH. (1996). Cell, 86, 47-57.
30. Rosenberg N. (1994). Semin. Cancer Biol., 5, 95-102.
31. Sawyers CL and Witte ON. (2001). The Molecular Basis of Blood Diseases, 3rd edn. Stamatoyannopoulos G, Majerus PW, Perlmutter RM and Varmus H (eds.), WB Saunders Company: Philadelphia.
32. Schaefer LK, Wang S and Schaefer TS. (2001). J. Biol. Chem., 276, 43074-43082.
33. Shalaby F, Ho J, Stanford WL, Fischer KD, Schuh AC, Schwartz L, Bernstein A and Rossant J. (1997). Cell, 89, 981-990.
34. Suzuki T, Shen H, Akagi K, Morse III HC, Malley JD, Naiman DQ, Jenkins NA and Copeland NG. (2002). Nat. Genet., 32, 166-174.
35. Tanaka T, Inazu T, Yamada K, Myint Z, Keng VW, Inoue Y, Taniguchi N and Noguchi T. (1999). Biochem. J., 339 (Part 1), 111-117.
36. Thomas PQ, Brown A and Beddington RS. (1998). Development, 125, 85-94.
37. Thorsteinsdottir U, Sauvageau G and Humphries K. (1997). Hematol. Oncol. Clin. N. Am., 11, 1221-1237.